MCC
LAB icon

Money Concepts Capital’s Standard BioTools LAB Stock Holding History

Money Concepts Capital’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$117 – 1828
2022
Q4 		$117 Buy
+100
New +$123 ﹤0.01% 3142
2021
Q1 		– Sell
-55,378
Closed -$332K – 744
2020
Q4 		$332K Buy
+55,378
New +$364K 0.03% 350

Other funds holding LAB

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Money Concepts Capital's LAB Position: Q1 2023 in Review

Money Concepts Capital sold out of Standard BioTools (LAB) in Q1 2023, closing a stake of 100 shares — an estimated $117 sold.

Money Concepts Capital first reported a position in LAB in Q4 2020 and held it in 2 quarters. The position peaked at $332K in Q4 2020. 69 funds tracked by Wall St. Rank hold LAB as of Q1 2023.

  • Money Concepts Capital reported no remaining Standard BioTools position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 100 Standard BioTools shares in Q1 2023, an estimated $117.
  • Money Concepts Capital first reported a position in Standard BioTools in Q4 2020 and held it in 2 quarters.
  • Money Concepts Capital's Standard BioTools position peaked at $332K in Q4 2020.
  • 69 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.